ClinicalTrialsFinder
RecruitingNCT03362164

Evaluation of HEArt invoLvement in Patients With FABRY Disease

Prospective Monocentric Cohort Study to Evaluate Predictors for Heart Failure and Sudden Cardiac Death in Patients With Fabry Disease

Sponsor

Wuerzburg University Hospital

Enrollment

650 participants

Start Date

Jan 1, 2001

Study Type

OBSERVATIONAL

Conditions

Rare DiseasesHypertrophic CardiomyopathyFabry DiseaseFabry Disease, Cardiac Variant

Summary

This study evaluates predictors for the incidence of arrhythmias and sudden cardiac death as well as terminal heart failure in patients with Fabry disease.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This trial is evaluating how Fabry disease — a rare inherited condition where a certain enzyme is missing, causing a harmful substance to build up in the body's organs — affects the heart, using detailed medical assessments and monitoring over time. **You may be eligible if...** - You have been genetically confirmed to have Fabry disease - You are 18 years or older - You are willing and able to sign an informed consent form **You may NOT be eligible if...** - You are unwilling or unable to provide informed consent - You have withdrawn your consent at any point Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(1)

Wuerzburg University Hospital

Würzburg, Bavaria, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03362164

Related Trials

Genetic Analysis of Uncommon Disease Presentations in Non-US Populations

NCT065959401 location

Fabry Disease Registry & Pregnancy Sub-registry

NCT00196742283 locations

Longitudinal Studies of Patient With FPDMM

NCT038543181 location

A Study of Patients With Fabry Disease (US Specific)

NCT069063678 locations

A Study of Migalastat in Pediatric Subjects (2 to <12 Yrs) With Fabry Disease and Amenable GLA Variants

NCT0690426111 locations